Journal
PHARMACOGENOMICS
Volume 14, Issue 8, Pages 969-980Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/PGS.13.75
Keywords
biomarker identification; biomarkers of susceptibility; prognostic and predictive biomarkers; subgroup identification; survival risk prediction
Categories
Ask authors/readers for more resources
Pharmacogenomics examines how the benefits and adverse effects of a drug vary among patients in a target population by analyzing genomic profiles of individual patients. Personalized medicine prescribes specific therapeutics that best suit an individual patient. Much current research focuses on developing genomic biomarkers to identify patients, to identify which patients would benefit from a treatment, have an adverse response, or no response at all, prior to treatment according to relevant differences in risk factors, disease types and/or responses to therapy. This review describes the use of the two personalized medicine biomarkers, prognostic and predictive, to classify patients into subgroups for treatment recommendation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available